Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of CHI-915 in Healthy Participants
Clinical trial NCT05210634 · COMPLETED
Trial details
- NCT number
- NCT05210634
- Sponsor
- Canopy Growth Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-11
- Primary completion
- 2022-05-06
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.